Florida faces staggering economic costs of $30.1 billion due to obesity
August 13, 2024 (Investorideas.com Newswire) Obesity and overweight are estimated to have caused a staggering $30.1 billion reduction in Florida's economy in 2022, equivalent to 2.2% of the state's gross domestic product, according to a report released by GlobalData, a leading data and analytics company.
GlobalData's report, 'Obesity's Impact on Florida's Economy and Labor Force,' analyzes the economic and workforce implications of obesity in the State of Florida, as well as the impact on state tax revenue collections and costs. Obesity is a serious, progressive disease and is associated with a range of other diseases, including type 2 diabetes, cardiovascular diseases, and musculoskeletal disorders.
In Florida, approximately one-third of adults are classified as having obesity (31.6%), and another third have overweight (34.5%) in 2022. This disease not only contributes to an increase in healthcare spending and premature death but also has a detrimental effect on labor force participation and productivity.
Estimates of the economic impact of obesity on Florida include: 253,100 fewer adults in the workforce due to obesity-related unemployment and premature death; $2.8 billion higher costs to employers for health-related absenteeism and disability; and 9% lower earnings for women with obesity compared to women with a healthy weight.
Employers in Florida paid an extra $3.5 billion in higher medical expenditures for health complications attributed to obesity and overweight. Households with private insurance incurred $2 billion in higher costs. Medicaid costs to the state were higher by over $646 million (equivalent to 7.2% of the state's Medicaid spending). The federal government also spent an estimated $6.7 billion more on Medicare and Medicaid for Florida residents.
Obesity and overweight have a detrimental impact on the state's budget, estimated at $2.15 billion in 2022, which is equivalent to 4.0% of fiscal year revenues. State tax revenues were lower by $950 million (1.8%) due to reduced economic activity, while state costs for Medicaid, public assistance, and state government health insurance increased by $1.2 billion.
The report also notes that achieving and maintaining weight loss of 5% to 25% among the Florida non-Medicare adult population with obesity could produce substantial medical savings, ranging from $16 billion to $39.3 billion over the next 10 years.
Dr. Pamela Romos Rama, MD, a Jacksonville-based cardiologist, comments: "Obesity in Florida carries a tremendous personal and social cost, impacting not only the health of individuals but also straining our healthcare system and economy. Effective treatment and proactive prevention efforts are essential to curbing this epidemic. By addressing obesity head-on, we can improve the quality of life for Floridians and reduce the significant economic burden it imposes on our state."
Considering the analysis, GlobalData has recommended actionable steps for state policymakers and employers:
State policymakers can (1) advocate for state employee health insurance to cover comprehensive, evidence-based obesity treatments, including intensive behavioral counseling, nutrition support, pharmacotherapy, and metabolic/bariatric surgery; (2) expand Medicaid coverage for obesity treatment; and (3) invest in community-based programs and education campaigns.
Employers can (1) offer insurance coverage and wellness programs for obesity care at parity with other chronic diseases; (2) foster a culture of support and inclusion that recognizes and accommodates the needs of employees with obesity; and (3) provide education and resources to employees to educate them about the health risks associated with obesity as well as strategies for obesity care and weight management.
GlobalData's report serves as a wakeup call to address the obesity crisis head-on, with the potential to alleviate the economic burden on Florida and foster a healthier and more prosperous future for its residents and employers.
The study was supported by Eli Lilly and Company.
For more information
To gain access to our latest press releases: GlobalData Media Centre
Analysts available for comment. Please contact the GlobalData Press Office:
EMEA & Americas: +44 (0)207 832 4399
Asia-Pacific: +91 40 6616 6809
Email: pr@globaldata.com
About GlobalData
4,000 of the world's largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData's unique data, expert analysis and innovative solutions, all in one platform. GlobalData's mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.
More Info:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp